| Aghazadeh Behzad | See Remarks | 7,905Common Stock, par value $0.0001 per share | — | Buy | |
|---|
| ORBIMED ADVISORS LLC | Director | 1,000,000Common Stock | — | Buy | |
|---|
| ORBIMED ADVISORS LLC | Director | 348,825Common Stock | — | Conversion | |
|---|
| GORDON CARL L | Director | 1,000,000Common Stock | — | Buy | |
|---|
| GORDON CARL L | Director | 348,825Common Stock | — | Conversion | |
|---|
| AH Bio Fund II, L.P. | 10% Owner | 333,333Common Stock | — | Buy | |
|---|
| AH Bio Fund II, L.P. | 10% Owner | 2,749,392Common Stock | — | Conversion | |
|---|
| Doudna Jennifer A | 10% Owner | 12,511Common Stock | — | Conversion | |
|---|
| Aghazadeh Behzad | See Remarks | 2,383,333Common Stock, par value $0.0001 per share | — | Buy | |
|---|
| Staahl Brett | 10% Owner | 19,385Performance-based Stock Option (Right to Buy) | — | Grant / award | |
|---|
